Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jimmy Park"'
Autor:
Steven Stone, Eliso Tikishvili, Jimmy Park, Julia Reid, Adib Younus, Zaina Sangale, Jerry S. Lanchbury, Emma H. Allott, Stephen J. Freedland, Leah R. Gerber, William Welbourn, Prabhakar Mithal
Publikováno v:
International Journal of Urology. 21:1209-1214
Objectives To determine whether PTEN status in prostate biopsy represents a predictor of intermediate and long-term oncological outcomes after radical prostatectomy, and whether PTEN status predicts response to androgen deprivation therapy. Methods I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d57a1db6ea2a461dbea7a6ee9d43b01
https://doi.org/10.1111/iju.12571
https://doi.org/10.1111/iju.12571
Autor:
Leah R. Gerber, Thorsten Schlomm, Jimmy Park, Zaina Sangale, Adib Younus, Stephen Freedland, Michael K. Brawer, William Welbourn, Guido Sauter, Jay T. Bishoff, Markus Graefen, Steven Stone, Alexander Gutin, Julia Reid, Jerry S. Lanchbury, Pierre Tennstedt, Eliso Tikishvili
Publikováno v:
Journal of Urology. 192:409-414
The cell cycle progression score is associated with prostate cancer outcomes in various clinical settings. However, previous studies of men treated with radical prostatectomy evaluated cell cycle progression scores generated from resected tumor tissu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e469e82479cdf2c444cbe57b658abe80
https://doi.org/10.1016/j.juro.2014.02.003
https://doi.org/10.1016/j.juro.2014.02.003
Autor:
Joseph K. Salama, Zaina Sangale, Jimmy Park, Alexander Gutin, Adib Younus, Julia Reid, William Welbourn, Leah R. Gerber, Eliso Tikishvili, Steven Stone, Jerry S. Lanchbury, Stephen J. Freedland
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 86:848-853
Purpose To evaluate the prognostic utility of the cell cycle progression (CCP) score, a RNA signature based on the average expression level of 31 CCP genes, for predicting biochemical recurrence (BCR) in men with prostate cancer treated with external
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56758cad8523da987119044174f72235
https://doi.org/10.1016/j.ijrobp.2013.04.043
https://doi.org/10.1016/j.ijrobp.2013.04.043
Autor:
Daniel M. Berney, Alexander Gutin, Jimmy Park, Jerry S. Lanchbury, David Mesher, Julia Reid, Christopher S. Foster, Henrik Møller, Adib Younus, Gabrielle Fisher, Michael C. Perry, Peter T. Scardino, Jack Cuzick, Steve Stone
Publikováno v:
British Journal of Cancer
Background: The natural history of prostate cancer is highly variable and it is difficult to predict. We showed previously that a cell cycle progression (CCP) score was a robust predictor of outcome in a conservatively managed cohort diagnosed by tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263e231154141dfeaea6cd80ed9aabbc
http://europepmc.org/articles/PMC3304411
http://europepmc.org/articles/PMC3304411
Autor:
Jorja D Warren, Adib Younus, V. O. Speights, Jerry S. Lanchbury, Darl D. Flake, Henrik Møller, Arthur R. Brothman, Daniel M. Berney, Jack Cuzick, Susanne Wagner, Gabrielle Fisher, Gregory P. Swanson, Steven Stone, Jimmy Park, David Mesher, Alexander Gutin, Julia Reid, Christopher S. Foster, Elzbieta Stankiewicz, Peter T. Scardino
Publikováno v:
The Lancet Oncology. 12:245-255
Summary Background Optimum management of clinically localised prostate cancer presents unique challenges because of the highly variable and often indolent natural history of the disease. To predict disease aggressiveness, clinicians combine clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42790e3d63abe435038564c5d703052f
https://doi.org/10.1016/s1470-2045(10)70295-3
https://doi.org/10.1016/s1470-2045(10)70295-3
Autor:
William Welbourn, Pierre Tennstedt, Thorsten Schlomm, Alexander Gutin, Adib Younus, Jimmy Park, Jay T. Bishoff, Leah R. Gerber, Stephen J. Freedland, Markus Graefen, Julia Reid, Steven Stone, Zaina Sangale, Eliso Tikishvili, Jerry S. Lanchbury, Michael K. Brawer, Guido Sauter
Publikováno v:
Journal of Urology. 191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4b08182e317423775a2a691d3d88d05
https://doi.org/10.1016/j.juro.2014.02.2518
https://doi.org/10.1016/j.juro.2014.02.2518
Autor:
Prabhakar, Mithal, Emma, Allott, Leah, Gerber, Julia, Reid, William, Welbourn, Eliso, Tikishvili, Jimmy, Park, Adib, Younus, Zaina, Sangale, Jerry S, Lanchbury, Steven, Stone, Stephen J, Freedland
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association. 21(12)
To determine whether PTEN status in prostate biopsy represents a predictor of intermediate and long-term oncological outcomes after radical prostatectomy, and whether PTEN status predicts response to androgen deprivation therapy.In a retrospective an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d41ec9fe9d842b25cdc098eedd743c03
https://pubmed.ncbi.nlm.nih.gov/25099119
https://pubmed.ncbi.nlm.nih.gov/25099119
Autor:
Jerry S. Lanchbury, Joseph K. Salama, Jimmy Park, Adib Younus, Zaina Sangale, Julia Reid, Alexander Gutin, Leah R. Gerber, Steven Stone, Eliso Tikishvili, Stephen J. Freedland, William Welbourn
47 Background: Accurate risk stratification improves decision making in localized prostate cancer. The CCP score, a prognostic RNA signature based on the average expression level of 31 cell cycle progression (CCP) genes, was developed to aid in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd4590e6838af2ebb17543b8432a15e
https://europepmc.org/articles/PMC3710548/
https://europepmc.org/articles/PMC3710548/
Autor:
Alexander Gutin, Stephen Freedland, Zaina Sangale, Leah R. Gerber, Eliso Tikishvili, Steven Stone, Joseph K. Salama, Jimmy Park, Julia Reid, Abid Younus, Jerry S. Lanchbury, William Welbourn
Publikováno v:
Journal of Urology. 189
kines studied were resistin, tumor necrosis factor (TNF), interleukin 6 (IL-6), nerve growth factor (NGF), hepatocyte growth factor (HGF) and monocyte chemoattractant protein?1 (MCP-1). Analyzed covariates were age, prostate specific antigen (PSA), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f805a4b168b5f0e8abd3543a188b653
https://doi.org/10.1016/j.juro.2013.02.2151
https://doi.org/10.1016/j.juro.2013.02.2151
Autor:
Guido Sauter, Michael K. Brawer, Adib Younus, Pierre Tennstedt, Jerry S. Lanchbury, William Welbourn, Jimmy Park, Leah R. Gerber, Julia Reid, Jay T. Bishoff, Zaina Sangale, Alexander Gutin, Thorsten Schlomm, Markus Graefen, Stephen J. Freedland, Steven Stone, Eliso Tikishvili
Publikováno v:
Journal of Clinical Oncology. 32:17-17
17 Background: We developed a prognostic RNA signature that is strongly associated with prostate cancer outcomes. The cell cycle progression (CCP) score has proven to have prognostic utility in predicting disease progression in various clinical setti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73771e0f3e04d97e97e4fe3305d0d51e
https://doi.org/10.1200/jco.2014.32.4_suppl.17
https://doi.org/10.1200/jco.2014.32.4_suppl.17